---
figid: PMC4417610__nihms561650f2
figtitle: Summary of the HGF/c-Met signaling pathway
organisms:
- NA
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC4417610
filename: nihms561650f2.jpg
figlink: /pmc/articles/PMC4417610/figure/F2/
number: F2
caption: Summary of the HGF/c-Met signaling pathway. HGF/c-Met signal transduction
  is initiated by binding of HGF to c-Met, as with other receptor tyrosine kinases.
  Dimerization or oligomerization of c-Met activates transphosphorylation of tyrosines
  (Tyr1234 and Tyr 1235) in the kinase domain followed by additional phosphorylation
  of other tyrosines (Tyr 1349 and Tyr 1356) in the C-terminal regulatory tail. Fully
  activated c-Met propagates HGF signaling in cells by recruiting and activating various
  adapter molecules downstream. Inhibitors of the HGF/c-Met signaling pathway, competitive
  inhibitors (A), tyrosine kinase inhibitors (B) or downstream inhibitors (C), target
  one of the molecular events of HGF/c-Met signaling activation and transduction.
papertitle: The hepatocyte growth factor/c-Met signaling pathway as a therapeutic
  target to inhibit angiogenesis.
reftext: Weon-Kyoo You, et al. BMB Rep. ;41(12):833-839.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9557271
figid_alias: PMC4417610__F2
figtype: Figure
redirect_from: /figures/PMC4417610__F2
ndex: 80c6cdcc-dee9-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4417610__nihms561650f2.html
  '@type': Dataset
  description: Summary of the HGF/c-Met signaling pathway. HGF/c-Met signal transduction
    is initiated by binding of HGF to c-Met, as with other receptor tyrosine kinases.
    Dimerization or oligomerization of c-Met activates transphosphorylation of tyrosines
    (Tyr1234 and Tyr 1235) in the kinase domain followed by additional phosphorylation
    of other tyrosines (Tyr 1349 and Tyr 1356) in the C-terminal regulatory tail.
    Fully activated c-Met propagates HGF signaling in cells by recruiting and activating
    various adapter molecules downstream. Inhibitors of the HGF/c-Met signaling pathway,
    competitive inhibitors (A), tyrosine kinase inhibitors (B) or downstream inhibitors
    (C), target one of the molecular events of HGF/c-Met signaling activation and
    transduction.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HGF
  - IL6
  - SOS1
  - MET
  - XYLT2
  - SOS2
  - PTK2
  - SRC
  - FGR
  - FYN
  - YES1
  - KRAS
  - HRAS
  - NRAS
  - STAT3
  - CTNND1
  - IGSF1
  - NOP2
  - RASA1
  - TRPA1
  - BRD8
  - NSUN5
  - GAB1
  - PIGU
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AKT1
  - AKT2
  - AKT3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - GRB2
  - Sos
  - Fak
  - Src42A
  - Csk
  - Src64B
  - ras
  - Ras64B
  - Ras85D
  - mip120
  - MetRS
  - Glg1
  - MTA1-like
  - Pi3K92E
  - p120ctn
  - dos
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Raf
  - Akt
  - Dsor1
  - Mtk
  - Erk7
  - rl
  - drk
  - Tyrosine
  - Tyr
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
